Brief: Tscan Therapeutics Reports Fourth Quarter And 2022 Financial Results

Tscan Therapeutics

08/03/2023 12:34

March 8 (Reuters) - Tscan Therapeutics Inc  TCRX.O :
    * TSCAN THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND HIGHLIGHTS UPCOMING MILESTONES
    * ENDED 2022 WITH CASH AND CASH EQUIVALENTS OF $120.0
MILLION,
FUNDING OPERATIONS INTO 2Q 2024
    * TSCAN THERAPEUTICS - REVENUE FOR THREE MONTHS ENDED
DECEMBER 31,
2022, WAS $3.1 MILLION, COMPARED TO $2.9 MILLION FOR THREE
MONTHS ENDED DECEMBER 31, 2021
    * QTRLY LOSS PER SHARE $0.78
    * Q4 EARNINGS PER SHARE VIEW $-0.70, REVENUE VIEW $3.8
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX7xs4TL 
Further company coverage:  TCRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))